Covered recipient · General Payments record
DEANNA L KLINE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$2,789.42
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $766.24 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $196.46 | 8 |
| Amgen Inc. | $151.42 | 3 |
| ABBVIE INC. | $73.98 | 4 |
| Novo Nordisk AS | $70.24 | 4 |
| PFIZER INC. | $65.45 | 3 |
| GlaxoSmithKline, LLC. | $34.46 | 2 |
| EISAI INC. | $27.91 | 1 |
| Phadia US Inc. | $18.47 | 1 |
| Exact Sciences Corporation | $18.41 | 1 |
| Acella Pharmaceuticals, LLC | $17.35 | 1 |
| Mylan Specialty L.P. | $16.73 | 1 |
| Esperion Therapeutics, Inc. | $15.66 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.59 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.17 | 1 |
| Lilly USA, LLC | $14.60 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.69 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107472214 | CMS |
| ABBVIE INC. | $14.02 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107472216 | CMS |
| ABBVIE INC. | $19.63 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107472218 | CMS |
| ABBVIE INC. | $21.64 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107472220 | CMS |
| Acella Pharmaceuticals, LLC | $17.35 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126637526 | CMS |
| Amgen Inc. | $10.18 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599972 | CMS |
| Amgen Inc. | $129.65 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599976 | CMS |
| Amgen Inc. | $11.59 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599974 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.59 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118180633 | CMS |
| Eisai Inc. | $27.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110799477 | CMS |
| Esperion Therapeutics, Inc. | $15.66 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129470292 | CMS |
| Exact Sciences Corporation | $18.41 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114495818 | CMS |
| GlaxoSmithKline, LLC. | $18.76 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116546039 | CMS |
| GlaxoSmithKline, LLC. | $15.70 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116592602 | CMS |
| Lilly USA, LLC | $14.60 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135548451 | CMS |
| Lundbeck LLC | $20.10 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046540 | CMS |
| Lundbeck LLC | $28.03 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046542 | CMS |
| Lundbeck LLC | $27.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046544 | CMS |
| Lundbeck LLC | $21.03 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046546 | CMS |
| Lundbeck LLC | $27.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046548 | CMS |
| Lundbeck LLC | $23.83 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046550 | CMS |
| Lundbeck LLC | $23.24 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046552 | CMS |
| Lundbeck LLC | $25.25 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146046554 | CMS |
| Mylan Specialty L.P. | $16.73 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147307457 | CMS |
| Novartis Pharmaceuticals Corporation | $14.34 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086997690 | CMS |
| Novo Nordisk Inc | $15.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100322408 | CMS |
| Novo Nordisk Inc | $19.47 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382095 | CMS |
| Novo Nordisk Inc | $17.38 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100478062 | CMS |
| Novo Nordisk Inc | $17.91 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373010 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.17 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119113747 | CMS |
| PFIZER INC. | $22.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131263110 | CMS |
| PFIZER INC. | $15.37 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131647436 | CMS |
| PFIZER INC. | $27.09 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131759310 | CMS |
| Phadia US Inc. | $18.47 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067577874 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.